AN2 Therapeutics, Inc. (ANTX)

AN2 Therapeutics, Inc. (ANTX) is a healthcare company (biotechnology) based in the United States. The share price is $4.23, down 5.37% on the day, which values the company at $160.5M. Price as of 18 Nov 2026, 11:43 UTC, from Yahoo Finance.

Key facts

Share price
$4.23−5.37% today
Market value
$160.5M
200-week average
$5.1718% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

AN2 Therapeutics, Inc. in more detail

ANTX trades at -5.5× next year's expected earnings. It sits 18% below its 200-week average of $5.17.

Worth checking: Share count keeps rising.

AN2 Therapeutics, Inc. (ANTX): questions and answers

What is AN2 Therapeutics, Inc.'s market cap?

AN2 Therapeutics, Inc. is valued at $160.5M at a share price of $4.23.

Is ANTX above its 200-week moving average?

No. ANTX is 18.1% below its 200-week average of $5.17. Long-term investors watch that line because strong companies rarely trade below it for long.

Does ANTX pay a dividend?

AN2 Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “AN2 Therapeutics, Inc. (ANTX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/ANTX

Underlying data: Yahoo Finance; company filings with the SEC.